OR WAIT null SECS
Click here to read the articles and download the PDF
A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.
Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.
Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.
April 17, 2024
Panel discussion uncovers how to alter one’s digital know-how for use in temperature-controlled supply chain.
The latest news for pharma industry insiders.
Masterclass session addresses looking beyond a dashboard by added capabilities with added value.
April 16, 2024
Company also purchased equipment for 12 good manufacturing practice clean rooms.
Capital also expected to assist the advancement of Evergreen's radiopharmaceutical discovery pipeline into clinical trials.
April 15, 2024
Results of the trial suggest that early intervention for intracerebral hemorrhage using parafascicular surgery were safe.
Phase IIa clinical trial of SPG60 for Fragile X syndrome offers hope for disease with no current FDA-approved treatment options.
April 12, 2024
A difference-in-differences analysis explores the correlation between direct-acting antiviral prescriptions for hepatitis C virus and the softening of state-level limitations.